bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
Antimicrobial resistance is a major public health issue across the globe. On September 4, 2019, we lost a partner in that mission. Stuart Levy, MD, one of the earliest and loudest voices warning of the dangers of antibiotic overuse in both humans and animals, passed away after a prolonged illness.
During our September 12, 2019 webinar, titled, “New Technology and Workflow Optimization in the Microbiology Lab: Working Together to Improve Patient Care,” Dr. Allison McMullen, Ph.D., D(ABMM), will share how microbiology is meeting today’s clinical challenges in the context of Antimicrobial Stewardship Programs (ASPs).
Lefamulin’s mechanism of action has a low inclination for developing resistance. The drug is a member of the pleuromutilin antibiotic class, and it has low propensity for cross resistance with a variety of antibiotic classes such as macrolide and tetracycline.
In August 2019, the CDC released an update on antibiotic use in the United States. The update includes data on antibiotic stewardship programs and resources, from 2018 studies. The CDC is continuously working to improve antibiotic prescribing and use as a part of the Antibiotic Resistance Solutions Initiative.
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
WASH, which stands for water, sanitation, and hygiene, are basic...